We recently detected the ESR1 A908G mutation at a low frequency of 6% in the primary invasive breast tumors of the Carolina Breast Cancer Study (CBCS), a population-based case-control study of mostly early stage breast cancer in North Carolina [12]. This evidence concerns the gene ESR1 and breast cancer.